Himadri Speciality Chemical Ltd. has received consideration relating to the conversion of warrants. This pertains to the balance 75% amount on allotment of equity shares on conversion of 3,07,800 warrants, out of a total of 10,817,000 warrants. The warrants were initially issued on May 14, 2024, at an issue price of ₹316 each, marking continued investor confidence in the company.
Warrant Conversion Update
Himadri Speciality Chemical Ltd. has announced the receipt of consideration related to the conversion of warrants into equity shares. This involves 3,07,800 warrants out of a total issue of 10,817,000.
Details of the Warrant Issue
The warrants were initially issued on May 14, 2024. Each warrant is convertible into one equity share at an issue price of ₹316. This conversion relates to a preferential allotment to promoters and certain non-promoter individuals.
Breakdown of Consideration Received
The company has received the balance 75% amount on allotment of equity shares upon the exercise of warrants. The original upfront payment of 25% was received on or before May 14, 2024, and September 09, 2024. Subsequent conversions and associated payments were also received on October 21, 2024, March 05, 2025, August 13, 2025, and October 16, 2025.
Individual Allotment and Amounts
Several allottees exercised their warrants. Asuray Choudhary and Amat Choudhary had the largest allocations of 60,00,000 and 40,00,000 warrants, respectively.
Outstanding Warrant Exercise
Some allottees, however, have not fully exercised their option for conversion. A list of these allottees has been provided by the management. The remaining balance to be received is tied to these unexercised warrants.
Source: BSE
